Hatch, A. J., Pang, H., Starr, M. D., Brady, J. C., Jia, J., Jiang, C., … Nixon, A. B. (2014). Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance). In Journal of Clinical Oncology (Vol. 32, pp. 11022–11022). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.11022

Hatch, Ace Joseph, Herbert Pang, Mark D. Starr, John C. Brady, Jingquan Jia, Chen Jiang, Alexander Sibley, et al. “Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance).” In Journal of Clinical Oncology, 32:11022–11022. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.11022.

Hatch AJ, Pang H, Starr MD, Brady JC, Jia J, Jiang C, et al. Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 11022–11022.

Hatch, Ace Joseph, et al. “Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance).” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 11022–11022. Crossref, doi:10.1200/jco.2014.32.15_suppl.11022.

Hatch AJ, Pang H, Starr MD, Brady JC, Jia J, Jiang C, Sibley A, Owzar K, Niedzwiecki D, Venook AP, Cushman SM, Hurwitz H, Nixon AB. Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 11022–11022.